News

Recent work by researchers at Massachusetts General Hospital (MGH) in the US has improved the accuracy of inserting long DNA fragments into genomes. This method might be used to introduce an entire wild-type or normal substitute gene, acting as a...

BeiGene, a global biotechnology company, announced that the U.S. FDA  has approved its Bruton’s tyrosine kinase inhibitor (BTKi) BRUKINSA (zanubrutinib) for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). “With four US approvals...

Why Kuehne+Nagel keeps investing in its European Pharma Fleet. If you’re a regular user of European highways, you have likely shared the road with a European pharma fleet (EPF) trailer. They are easy to spot with their pristine white body...

EyePoint Pharmaceuticals, Inc., a company developing and commercializing therapeutics for serious eye disorders, has entered into a lease agreement to design and construct a 40,000-sq.-ft. manufacturing facility in Northbridge, MA to support the global manufacturing of programs, including EYP-1901...

CytoReason, a pioneer in computational disease modeling, expanded its collaboration with Sanofi. The multiyear collaboration will further Sanofi’s target discovery efforts via CytoReason’s AI platform in the field of inflammatory bowel disease (IBD), to identify patient subtypes and pair...

Weight loss and staying healthy is an issue that most people are struggling with, and for others, losing excess weight is proving to be a tough goal to achieve. Losing the extra weight depends on different things, including: lifestyle ...

The current EU antibiotic shortages are being closely watched, according to the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), which has also declared that it is taking action. Through the Executive Steering Group on Shortages and...